These data suggest that HCaRG inhibited tumor growth of RCCs by maintaining a more differentiated phenotype and by controlling cell proliferation, suggesting a role of HCaRG as a tumor-suppressor gene in RCC. Here, COMMD5 is linked to renal cell carcinoma.